within Pharmacolibrary.Drugs.ATC.C;

model C07AB07
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.88,
    Cl             = 0.00025,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.13,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600,            
    Vdp             = 0.21,
    k12             = 16,
    k21             = 16
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C07AB07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Bisoprolol is a cardioselective beta-1 adrenergic receptor blocker used for the treatment of arterial hypertension, chronic stable angina pectoris, and chronic heart failure. It is widely approved and used today for cardiovascular indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Horikiri, Y, et al., &amp; Mizobe, M (1997). Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs. <i>Journal of pharmaceutical sciences</i> 86(5) 560–564. DOI:<a href=&quot;https://doi.org/10.1021/js960453v&quot;>10.1021/js960453v</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9145379/&quot;>https://pubmed.ncbi.nlm.nih.gov/9145379</a></p></li><li><p>Le Coz, F, et al., &amp; Jaillon, P (1991). Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteers. <i>Journal of cardiovascular pharmacology</i> 18(1) 28–34. DOI:<a href=&quot;https://doi.org/10.1097/00005344-199107000-00005&quot;>10.1097/00005344-199107000-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1719288/&quot;>https://pubmed.ncbi.nlm.nih.gov/1719288</a></p></li><li><p>Kirch, W, et al., &amp; Ohnhaus, EE (1987). Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease. <i>Clinical pharmacokinetics</i> 13(2) 110–117. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198713020-00003&quot;>10.2165/00003088-198713020-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2887325/&quot;>https://pubmed.ncbi.nlm.nih.gov/2887325</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C07AB07;
